Colitis Center News Today

WASHINGTON — Patients with Crohn’s disease who ate a catered low-fat, high-fiber diet for 8 weeks experienced improvements in symptoms, inflammation and quality of life vs. those offered counseling alone, researchers reported. “We know that most patients with Crohn’s disease seek dietary counseling and ask their physicians about the foods they should consume,” Hajar

To celebrate World Digestive Health Day on May 29, the World Gastroenterology Organization launched a campaign, “Your Digestive Health: Make It A Priority,” to boost awareness on the vital role the digestive system plays in overall health.The public advocacy campaign focuses on the importance of prioritizing digestive health to maintain quality of life and overall wellbeing and, by

The monoclonal antibody in development as maintenance therapy for people with moderately to severely active ulcerative colitis was more effective than placebo.

WASHINGTON — “Even at short intervals,” an intermittent low-calorie, plant-based diet may improve inflammation and response to medical therapy among patients with moderately to severely active ulcerative colitis, according to a presenter. “Diet plays a role in IBD inflammation but there are very few clinical trials that examine the impact of diet on UC and, to my

A diagnosis of chronic kidney disease was approximately 3-times more likely in Crohn's disease than in ulcerative colitis.

Bruce Sands, MD, MS.,Dr. Burrill B. Crohn Professor of Medicine, Icahn School of Medicine at Mount Sinai and System Chief, Division of Gastroenter...

Bruce Sands, MD, MS., Dr. Burrill B. Crohn Professor of Medicine, Icahn School of Medicine at Mount Sinai and System Chief, Division of Gastroenterology,...

Don’t let irritable bowel syndrome prevent you from enjoying the festive season. Follow these 9 tips to minimize triggers and maximize fun.

Researchers found significant improvements for intestinal microbiota transplant in one type of inflammatory bowel disease but not another.

/PRNewswire/ -- Adiso Therapeutics, Inc., a clinical-stage biotechnology company developing novel medicines targeting chronic inflammatory diseases today...